Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1850 of 2873 entries
View as:

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01404936 Org: User:
Start: 07/31/96 End: 12/31/11 Due: 12/31/12

INCB018424 in Patients With Advanced Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00674479 Org: User:
Start: 05/12/08 End: 03/23/17 Due: 03/23/18

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00254384 Org: User:
Start: 10/05/05 End: 05/21/24 Due: 05/21/25

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06108232 Org: User:
Start: 03/15/24 End: 12/31/27 Due: 12/31/28

TKI258 in Castrate Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00831792 Org: User:
Start: 04/07/10 End: 06/12/17 Due: 06/12/18

Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine

Phase: N/A Priority: Normal
NCT ID: NCT00608933 Org: User:
Start: 06/30/08 End: 12/07/20 Due: 12/07/21

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00038818 Org: User:
Start: 05/31/01 End: 12/31/02 Due: 12/31/03

An Exploratory Study on Optical Assessment of Oral Mucositis

Phase: N/A Priority: Normal
NCT ID: NCT00488332 Org: User:
Start: 03/31/06 End: 07/31/10 Due: 07/31/11

Robotic Harvest of the Latissimus Dorsi (LD) Muscles

Phase: N/A Priority: Normal
NCT ID: NCT02274493 Org: User:
Start: 07/08/15 End: 03/07/18 Due: 03/07/19

Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their Partners

Phase: N/A Priority: Normal
NCT ID: NCT02481349 Org: User:
Start: 06/16/15 End: 04/30/27 Due: 04/30/28

Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study

Phase: N/A Priority: Normal
NCT ID: NCT04837118 Org: User:
Start: 02/15/21 End: 12/31/26 Due: 12/31/27

Cellular Therapy With Cord Blood Cells

Phase: N/A Priority: Normal
NCT ID: NCT00427557 Org: User:
Start: 10/31/06 End: 11/30/10 Due: 11/30/11

Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03518112 Org: User:
Start: 04/18/18 End: 05/27/21 Due: 05/27/22

Active Living After Cancer: Implementation Within Be Well Acres Homes

Phase: N/A Priority: Normal
NCT ID: NCT06907706 Org: User:
Start: 04/03/23 End: 04/30/29 Due: 04/30/30

Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.

Phase: N/A Priority: Normal
NCT ID: NCT00837499 Org: User:
Start: 01/01/07 End: 05/10/21 Due: 05/10/22

Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy

Phase: N/A Priority: Normal
NCT ID: NCT05093712 Org: User:
Start: 06/28/21 End: 03/23/22 Due: 03/23/23

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

Phase: N/A Priority: Normal
NCT ID: NCT01390402 Org: User:
Start: 01/31/12 End: 11/30/14 Due: 11/30/15

Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

Phase: N/A Priority: Normal
NCT ID: NCT02597478 Org: User:
Start: 01/04/16 End: 01/27/21 Due: 01/27/22

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients with Inflammatory or Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00477100 Org: User:
Start: 04/17/07 End: 04/30/30 Due: 04/30/31

Study of 18F-Fluoro-PEG6-IPQA

Phase: N/A Priority: Normal
NCT ID: NCT01320059 Org: User:
Start: 02/29/12 End: 04/30/16 Due: 04/30/17

TPI 287 in Breast Cancer Metastatic to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT01332630 Org: User:
Start: 08/16/11 End: 04/14/17 Due: 04/14/18

Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project

Phase: N/A Priority: Normal
NCT ID: NCT02459002 Org: User:
Start: 07/18/12 End: 03/13/23 Due: 03/13/24

Acupuncture for Chemo-Induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00891618 Org: User:
Start: 04/30/09 End: 04/30/13 Due: 04/30/14

PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00276523 Org: User:
Start: 02/29/04 End: 03/31/06 Due: 03/31/07

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03943173 Org: User:
Start: 06/07/19 End: 06/27/25 Due: 06/27/26